EP Patent

EP4674401A3 — Container accommodating an aqueous ophthalmic composition comprising delgocitinib

Assigned to Rohto Pharmaceutical Co Ltd · Expires 2026-02-25 · 0y expired

What this patent protects

The present invention relates to an aqueous composition comprising delgocitinib or a salt thereof and having a pH of 4.0 to 6.5.

USPTO Abstract

The present invention relates to an aqueous composition comprising delgocitinib or a salt thereof and having a pH of 4.0 to 6.5.

Drugs covered by this patent

Corectim (DELGOCITINIB) · Japan Tobacco

Patent Metadata

Patent number: EP4674401A3
Jurisdiction: EP
Classification: —
Expires: 2026-02-25
Drug substance claim: No
Drug product claim: No
Assignee: Rohto Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.